Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1671284/000167128422000039/bhg-20220630.htm
May 2024
May 2024
April 2024
March 2024
January 2024
January 2024
January 2024
December 2023
December 2023
November 2023
As of June 30, | |||||||||||
2022 | 2021 | ||||||||||
Consumer and Patient Metrics | |||||||||||
Bright HealthCare Commercial Consumers | 970,000 | 550,000 | |||||||||
Bright HealthCare Medicare Advantage Consumers | 120,000 | 110,000 | |||||||||
NeueHealth Value-Based Patients | 500,000 | 40,000 |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
($ in thousands) | June 30, | June 30, | |||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Financial Metrics | |||||||||||||||||||||||
Revenue | $ | 1,576,628 | $ | 1,113,840 | $ | 3,412,203 | $ | 1,988,398 | |||||||||||||||
Medical Cost Ratio (1) | 88.8 | % | 86.8 | % | 86.6 | % | 83.5 | % | |||||||||||||||
Operating Cost Ratio | 26.2 | % | 23.4 | % | 24.4 | % | 23.6 | % | |||||||||||||||
GAAP Net Loss | $ | (251,330) | $ | (43,723) | $ | (431,959) | $ | (68,268) | |||||||||||||||
Adjusted EBITDA (non-GAAP) | $ | (194,860) | $ | (93,766) | $ | (269,690) | $ | (107,593) |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1671284/000167128422000039/bhg-20220630.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Bright Health Group Inc..
Bright Health Group Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Rating
Learn More
Non-GAAP Financial Measures Adjusted EBITDA We define Adjusted EBITDA as net loss excluding interest expense, income taxes, depreciation and amortization, any impairment of intangible assets, adjusted for the impact of acquisition and financing-related transaction costs, share-based compensation, changes in the fair value of equity securities, changes in the fair value of contingent consideration, contract termination costs and restructuring costs.
The three and six months ended June 30, 2022 also include a net increase of $36.8 million of premium deficiency reserve expense due to expected future losses in certain markets in 2022 in our Bright HealthCare segment.
The three and six months ended June 30, 2022 also include a net increase of $36.8 million of premium deficiency reserve expense due to expected future losses in certain markets in 2022 in our Bright HealthCare segment.
In addition, we experienced increases in operating costs from new market entry and increased marketing and selling expenses.
In addition, two DCEs aligned with our NeueHealth segment began participating in the DC Model effective January 1, 2022, which contributed $137.2 million of the increase in total revenue.
Key Metrics and Non-GAAP Financial...Read more
The acquisition of Zipnosis on...Read more
The increase in service revenue...Read more
Management believes Adjusted EBITDA is...Read more
The three and six months...Read more
The increase was primarily attributable...Read more
We expect to continue our...Read more
Adjusted EBITDA has been presented...Read more
The increase was driven by...Read more
Effective April 1, 2021, we...Read more
Our second quarter of 2022...Read more
Management uses Adjusted EBITDA to...Read more
The remaining increase was primarily...Read more
We used a portion of...Read more
31 Table of Contents (1)See...Read more
40 Table of Contents Investing...Read more
is built upon the belief...Read more
Total revenues increased by $462.8...Read more
Our operating cost ratio of...Read more
Our operating cost ratio of...Read more
This discussion should be read...Read more
We believe the operational improvements...Read more
Effective July 1, 2021, we...Read more
Our risk adjustment performance is...Read more
This increase is driven by...Read more
Financing Activities During the six...Read more
Service revenue increased by $5.0...Read more
Service revenue increased by $13.5...Read more
Operating costs for the six...Read more
In the second quarter of...Read more
The increase in revenues in...Read more
We have also made improvements...Read more
For example: Through our medical...Read more
The increases in premium revenue...Read more
The increases in premium revenue...Read more
The increase in premium revenue...Read more
Commercial revenue increased by $261.3...Read more
Commercial revenue increased by $803.5...Read more
We've driven an improvement in...Read more
During the second quarter, we...Read more
- is built on the...Read more
Medicare Advantage revenue increased by...Read more
Medicare Advantage revenue increased by...Read more
34 Table of Contents Total...Read more
In July 2022, we borrowed...Read more
Depreciation and amortization increased by...Read more
Depreciation and amortization increased by...Read more
Our longer-term future capital requirements...Read more
(c)Beginning in 2022, Adjusted EBITDA...Read more
On a segment basis, Bright...Read more
Our consolidated revenues increased 41.5%...Read more
The increase in both 2022...Read more
Both 2022 periods also experienced...Read more
We may seek funds through...Read more
39 Table of Contents As...Read more
We also expect to drive...Read more
In addition, we repaid $155.0...Read more
These and other responses to...Read more
This NeueHealth acquisition was completed...Read more
The increase in operating costs...Read more
Because not all companies use...Read more
37 Table of Contents Premium...Read more
Premium revenue increased by $666.6...Read more
(b)Represents non-cash compensation expense related...Read more
We are also upgrading our...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Bright Health Group Inc. provided additional information to their SEC Filing as exhibits
Ticker: BHG
CIK: 1671284
Form Type: 10-Q Quarterly Report
Accession Number: 0001671284-22-000039
Submitted to the SEC: Fri Aug 12 2022 5:58:09 PM EST
Accepted by the SEC: Mon Aug 15 2022
Period: Thursday, June 30, 2022
Industry: Hospital And Medical Service Plans